As Merck looks for growth opportunities ahead of Keytruda’s tumble over the patent cliff, the company’s future now looks a ...

Currax Pharmaceuticals LLC ("Currax"), a pharmaceutical, company that delivers life-changing medicines to patients with ...

EDP-323 significantly reduced mean viral load AUC by 85% and 87% in the high- and low-dose groups, respectively, compared ...

Lantern Pharma (LTRN) announced the presentation of clinical data from its ongoing Phase 1 trial of LP-284 at the 25th Annual Lymphoma, Leukemia & ...

Beyond R&D, AI is transforming the way biopharma companies commercialise therapies and interact with healthcare providers and patients. In a marketplace increasingly driven by personalised experiences ...

Eli Lilly said on Tuesday it was collaborating with Nvidia to build a supercomputer to help with drug discovery and shorten ...

Experts say that sectors such as pharma, energy and infra give banks the opportunity to get “hard collateral” (such as land, ...

Q3 2025 Earnings Call Transcript October 27, 2025 BioMarin Pharmaceutical Inc. misses on earnings expectations. Reported EPS ...

Synthetic audience testing is here to stay, but its value depends on how it’s done. Resonance Read introduces a more behaviorally precise, evidence-based way forward.

The company points to “emerging research” that shows GLP-1RA medications offer benefits beyond weight loss for patients ...

Recruitment of Three Additional Pediatric Patients in Austria and Ireland Achieves Investigator Study TargetCurrent Pediatric Patient in Ongoing Study Has Completely Healed Skin After 9 months of ...

One of India’s most respected and highly followed super investors, Ashish Dhawan has just sold off one of his favourite ...